tirzepatide fda submission confirms shortage is still over, gives compounders a grace period De-Risking FDA Abbreviated New Drug

And Im here to help. Nutritional modulation of endogenous glucagon-like peptide-1 secretion: a review Exercise and glucagon-like peptide-1: Does exercise potentiate the effect of treatment

Further research, including clinical trials, will be needed to understand whether GLP-1 medicines have a direct effect. Gareth Jones, the director of corporate affairs at the National Pharmacy Association, said: This is a significant study and shows that weight loss treatment may have potential to give important additional therapeutic benefits

Journal Reference : Moiz Lakhani, Abdullah Al-Ani, Marko Popovic, tienne Bnard-Sguin, Edward Margolin

doi:10.1371/journal.pone.0100777 25